Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NRL | hg38_v1_chr14_-_24084625_24084641 | -0.26 | 1.6e-01 | Click! |
MAF | hg38_v1_chr16_-_79600698_79600723 | 0.09 | 6.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_116829898 Show fit | 11.38 |
ENST00000227667.8
ENST00000375345.3 |
apolipoprotein C3 |
|
chr4_+_77605807 Show fit | 10.63 |
ENST00000682537.1
|
C-X-C motif chemokine ligand 13 |
|
chr1_-_56966133 Show fit | 10.61 |
ENST00000535057.5
ENST00000543257.5 |
complement C8 beta chain |
|
chr1_-_56966006 Show fit | 9.97 |
ENST00000371237.9
|
complement C8 beta chain |
|
chr11_+_116830529 Show fit | 8.45 |
ENST00000630701.1
|
apolipoprotein C3 |
|
chr22_+_20774092 Show fit | 7.50 |
ENST00000215727.10
|
serpin family D member 1 |
|
chr1_+_207104226 Show fit | 6.07 |
ENST00000367070.8
|
complement component 4 binding protein alpha |
|
chr1_+_207104287 Show fit | 5.99 |
ENST00000421786.5
|
complement component 4 binding protein alpha |
|
chr5_-_156963222 Show fit | 5.80 |
ENST00000407087.4
ENST00000274532.7 |
T cell immunoglobulin and mucin domain containing 4 |
|
chr19_+_44914247 Show fit | 5.51 |
ENST00000588750.5
ENST00000588802.5 |
apolipoprotein C1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 41.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.4 | 25.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
5.0 | 19.8 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
3.6 | 14.5 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.1 | 12.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.3 | 12.1 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.2 | 11.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
2.7 | 10.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 8.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.6 | 8.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 61.3 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 31.5 | GO:0072562 | blood microparticle(GO:0072562) |
2.8 | 25.1 | GO:0005579 | membrane attack complex(GO:0005579) |
2.9 | 23.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 18.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 16.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.7 | 14.9 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 8.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 5.2 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 4.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 31.2 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 28.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
4.7 | 23.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.8 | 14.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 13.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 13.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
2.1 | 10.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 8.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 6.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 6.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 34.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 12.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 10.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 9.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 8.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 7.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 6.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 3.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 3.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 44.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.9 | 23.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 9.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 8.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 8.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 7.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 6.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 5.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 4.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 4.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |